Lipid interaction of α-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2

Journal of Neurochemistry

Volumn 84, Issue 5, 2003, Pages 1128-1142

  Lee, Eui Nam ^a   Lee, Sun Young ^a   Lee, Daekyun ^a   Kim, Jongsun ^b   Paik, Seung R ^a  

^a Inha University School of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

synuclein; Copper; Lipid interaction; Metal catalyzed oxidation; Parkinson's disease; Self oligomerization

Indexed keywords

2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; ALPHA SYNUCLEIN; ARACHIDONIC ACID; BETA SYNUCLEIN; COPPER; HYDROGEN PEROXIDE; LIPID; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CROSS LINKING; LEWY BODY; LIPID MEMBRANE; MICELLE; MOLECULAR INTERACTION; NERVE DEGENERATION; NONHUMAN; OLIGOMERIZATION; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LIPID INTERACTION;

ALPHA-SYNUCLEIN; BETA-SYNUCLEIN; CATALYSIS; COPPER; CROSS-LINKING REAGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HYDROGEN PEROXIDE; LIPIDS; MACROMOLECULAR SUBSTANCES; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; PHOSPHATIDYLINOSITOLS; PROTEIN BINDING; QUINOLINES; RECOMBINANT PROTEINS; SPECTROMETRY, FLUORESCENCE; SYNUCLEINS;

EID: 0037341187     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01612.x     Document Type: Article

References (64)

1. Baba M., Nakajo S., Tu P.-H., Tomita T., Nakaya K., Lee V. M.-Y., Trojanowski J. Q. and Iwatsubo T. (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879-884.
2. Brown D. R., Qin K., Herms J. W., Madiung, A., Manson J., Strome, R., Fraser P. E., Kruck T., Bohlen A., Schulz-Schaeffer W., Giese A., Westaway D. and Kretzschmar H. (1997) The cellular prion protein binds copper in vivo. Nature 390, 684-687.
3. Bruijn L., Houseweart M. K., Kata S., Anderson K. L., Anderson, S. D., Ohama E., Reaume A. G., Scott R. W. and Cleveland D. W. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type. SOD1. Science 281, 1851-1854.
4. Bush A. I. (2000) Metals and neuroscience. Curr. Opin. Chem. Biol. 4, 184-191.
5. Bush A. I., Pettingell W. H., Multhaup G., Paradis M. D. Vonsattel J.-P., Gusella J. F., Beyreuther K., Masters C. L. and Tanzi R. E. (1994) Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265, 1464-1467.
6. Castellani R. J., Siedlak S. L., Perry G. and Smith M. A. (2000) Sequestration of iron by Lewy bodies in Parkinson's disease. Acta Neuropathol. 100, 111-114.
7. Clayton D. F. and George J. M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21, 249-254.
8. Clayton D. F. and George J. M. (1999) Synueleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res. 58, 120-129.
9. Cole N. B., Murphy D. D., Grider T., Rueter S., Brasaemle D. and Nussbaum R. L. (2002) Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein. J. Biol. Chem. 277, 6344-6352.
10. Conway K. A., Rochet J.-C., Bieganski R. M. and Lansbury P. T. Jr (2001) Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuelein adduct. Science 294, 134-1349.
11. Davidson W. S., Jonas A., Clayton D. F. and George J. M. (1998) Stabilizaton of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443-9449.
12. Eliezer D., Kutluay E., Bussell R. Jr and Browne G. (2001) Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061-1073.
13. Feany M. B. and Bender W. W. (2000) A Drosophila model of Parkinson's disease. Nature 404, 394-398.
14. Fisher L. J. and Gage F. H. (1995) Novel therapeutic directions for parkinson's disease. Mol. Med. Today 1, 181-187.
15. Forno L. S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259-272.
16. Gai W. P., Yuan H. X., Li X. Q., Power J. T. H., Blumbergs P. C. and Jensen P. H. (2000) In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol 166, 324-333.
17. Giasson B. I., Duda J. E., Murray I. V. J., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q. and Lee V. M.-Y. (2000) Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 290, 985-989.
18. Gilgun-Sherki Y., Melamed E. and Offen D. (2001) Oxidative stress-induced neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40, 959-975.
19. Goldberg M. S. and Lansbury P. T. Jr (2000) Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? Nat. Cell Biol, 2, E115-E119.
20. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
21. Hardy J. and Gwinn-Hardy K. (1998) Genetic classification of primary neurodegenerative disease. Science 282, 1075-1079.
22. Hashimoto M., Hsu L., Xia Y., Takeda A., Sisk A., Sundsmo M. and Masliah E. (1999) Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro. Neuroreport 10, 717-721.
23. Huang X., Atwood C. S., Hartshom M. A., Multhaup G., Goldstein L. E., Scarpa R. C., Cuajungco M. P., Gray D. N., Lim J., Moir R. D., Tanzi R. E. and Bush A. 1. (1999) The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609-7616.
24. Jakes R., Spillantini M. G. and Goedert M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27-32.
25. Jo E., MeLaurin J., Yip C. M., George-Hyslop P. St. and Fraser P. E. (2000) α-Synuclein membrane interactions and lipid specificity. Biol. Chem. 275, 34328-34334.
26. Kim J. (1997) Evidence that the precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil. Mol. Cells 7, 78-83.
27. Kim Y.-S., Lee D., Lee E.-K., Sung J. Y., Chung K. C., Kim J. and Paik S. R. (2001) Multiple ligand interaction of α-synuclein produced various forms of protein aggregates in the presence of Aβ25-35, copper, and eosin. Brain Res. 908, 93-98.
28. Koo E. H., Lansbury P. T. Jr and Kelly J. W. (1999) Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl Acad. Sci. USA 96, 9989-9990.
29. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J. T., Schöls L. and Riess O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet. 18, 10-108.
30. Lansbury P. T. Jr (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl Acad. Sci. USA 96, 3342-3344.
31. Lee D., Lee E.-K., Lee J.-H., Chang C.-S. and Paik S. R. (2001) Self-oligomerization and protein aggregation of α-synuclein in the presence of Coomassie Brilliant Blue. Eur. J. Biochem. 268, 295-301.
32. Lee H.-J., Choi C. and Lee S.-J. (2002) Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277, 671-678.
33. Lee J.-H., Shin H.-J., Chang C.-S. and Paik S. R. (1998) Comparisons of the NACP self-oligomerizations induced by Aβ25-35 in the presence of dicyclohexylcarbodiimide and N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline. Neurochem. Res. 23, 1427-1434.
34. Leng Y., Chase T. N. and Bennett M. C. (2001) Muscarinic receptor stimulation induces translocation of an α-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasm. J. Biol. Chem. 276, 28212-28218.
35. Lokanadam B., Gupta P. D. and Ramasami T. (2000) A novel and single step ultrastructural method for staining biological tissues embedded in common embedding media. J. Submicrosc. Cytol. Pathol. 32, 131-135.
36. Lozano A. M., Lang A. E., Hutchison W. D. and Dostrovsky J. O. (1998) New developments in understanding the etiology of Parkinson's disease and in its treatment. Curr. Opin. Neurobiol. 8, 783-790.
37. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A. and Mucke L. (2000) Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269.
38. Montine T. J., Farris D. B. and Graham D. G. (1995) Covalent cross-linking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation. J. Neuropathol. Exp. Neurol. 54, 311-319.
39. Morrissey J. H. (1981) Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal. Biochem. 105, 307-310.
40. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C. L. & Beyreuther K. (1996) The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science 271, 1406-1409.
41. Narayanan V. and Scarlata S. (2001) Membrane binding and self association of α-synucleins. Biochemistry 40, 9927-9934.
42. Paik S. R., Lee J.-H., Kim D.-H., Chang C.-S. and Kim J. (1997) Aluminum-induced structural alterations of the precursor of the non-Aβ component of Alzheimer's disease amyloid. Arch. Biochem. Biophys. 344, 325-334.
43. Paik S. R., Lee J.-H., Kim D.-H., Chang C.-S. and Kim Y.-S. (1998) Self-oligomerization of NACP, the precursor protein of the non- amyloid β/A4 protein (Aβ) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal Aβ fragment (residues 25-35). FEBS Lett. 421, 73-76.
44. Paik S. R., Shin H.-J., Lee J.-H., Chang C.-S. and Kim J. (1999) Copper (II)-induced self-oligomerization of α-synuclein. Biochem. J. 340, 821-828.
45. Paik S. R., Shin H.-J. and Lee J.-H. (2000) Metal-catalyzed oxidation of α-synuclein in the presence of Copper (II) and hydrogen peroxide. Arch. Biochem. Biophys. 378, 269-277.
46. Pall H. S., William A. C., Blake D. R., Lunee J., Gutteridge J. M., Hall M. and Taylor A. (1987) Raised cerebrospinal-fluid copper concentration in Parkinson's disease, Lancet 2, 238-241.
47. Penefsky H. S. (1977) Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase. J. Biol. Chem. 252, 2891-2899.
48. Perrin R. J., Woods W. S., Clayton D. F. and George J. M. (2001) Exposure to long-chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J. Biol. Chem. 276, 41958-41962.
49. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos, E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Iorio G. D., Golbe L. I. and Nussbaum R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
50. Sharon R., Goldberg M. S., Bar-Josef I., Betensky R. A., Shen J. and Selkoe D. J. (2001) α-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc. Natl Acad. Sci. USA 98, 9110-9115.
51. Shin H.-J., Lee E.-K., Lee J.-H., Lee D., Chang C.-S., Kim Y.-S. and Paik S. R. (2000) Eosin interaction of α-synuclein leading to protein self-oligomerization. Biochim. Biophys. Acta 1481, 139-146.
52. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J. and Klenk D. C. (1985) Measurement of protein using bieinchoninie acid. Anal. Biochem. 150, 76-85.
53. Smith M. A., Harris P. L. R., Sayre L. M. and Perry G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl Acad. Sci. USA 94, 9866-9868.
54. Souza J. M., Giasson B. I., Chen Q., Lee V. M.-Y. and Ischiropoulos H. (2000) Dityrosine cross-linking promotes formation of stable α-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275, 18344-18349.
55. Spillantini M. G., Schmidt M. L., Lee V. M.-Y., Trojanowski J. Q., Jakes R. and Goedert M. (1997) α-Synuclein in Lewy bodies. Nature 388, 839-840.
56. Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M. and Goedert M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469-6473.
57. Stadtman E. R. (1992) Protein oxidation and aging. Science 257, 1220-1224.
58. Turnbull S., Tabner B. J., El-Agnaf O. M. A., Moore S., Davies Y. and Allsop D. (2001) α-Synuclien implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. Free Radic. Biol. Med. 30, 1163-1170.
59. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D. A. C., Kondo J., Ihara Y. and Saitoh T. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc. Natl Acad. Sci. USA 90, 11282-11286.
60. Uversky V. N., Gillepsie J. R. and Fink A. L. (2000) Why are 'natively unfolded' proteins unstructured under physiologic conditions? Proteins 41, 415-427.
61. Volles M. J., Lee S.-J., Rochet J.-C., Shtilerman M. D., Ding T. T., Kessler J. C. and Lansbury P. T. Jr (2001) Vesicle permeabilization by protofibrillar α-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40, 7812-7819.
62. Weiareb P. H., Zhen W., Pooa A. W., Conway K. A. and Lansbury P. T. (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709-13715.
63. Zhang X., Jackson J. K. and Burt H. M. (1996) Determination of surfactant critical micelle concentration by a novel fluorescence depolarization technique. J. Biochem. Biophys. Meth 31, 145-150.
64. Zhang Y., Dawson V. L. and Dawson T. M. (2000) Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7, 240-250.